Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Capital Employed (2021 - 2026)

Rani Therapeutics Holdings' Return on Capital Employed history spans 6 years, with the latest figure at 83.67% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 41678.0% to 83.67% in Q1 2026 year-over-year; TTM through Mar 2026 was 83.67%, a 41678.0% increase, with the full-year FY2025 number at 109.59%, up 8510.0% from a year prior.
  • Return on Capital Employed came in at 83.67% for Q1 2026, up from 176.45% in the prior quarter.
  • The five-year high for Return on Capital Employed was 44192.83% in Q2 2025, with the low at 500.45% in Q1 2025.
  • Historically, Return on Capital Employed has averaged 2517.79% across 5 years, with a median of 83.67% in 2026.
  • Peak annual rise in Return on Capital Employed hit 4437338bps in 2025, while the deepest fall reached -35020bps in 2025.
  • Year by year, Return on Capital Employed stood at 61.42% in 2022, then tumbled by -92bps to 117.64% in 2023, then plummeted by -124bps to 263.99% in 2024, then soared by 33bps to 176.45% in 2025, then skyrocketed by 53bps to 83.67% in 2026.
  • Business Quant data shows Return on Capital Employed for RANI at 83.67% in Q1 2026, 176.45% in Q4 2025, and 795.18% in Q3 2025.